Limbus Medical Technologies achieves C5 attestation for the varvis® software
Rostock, Germany, November 4, 2025 — Limbus Medical Technologies GmbH, a medical device manufacturer and software development company based in Rostock, Germany, has achieved C5 attestation (type 1). This milestone reinforces the company's commitment to information security in cloud-based clinical genomics. For laboratories and hospitals, the result is a certified, secure cloud service that supports their compliance requirements.
“C5 attestation confirms what our customers expect from us: that sensitive clinical data is handled in a secure, certified cloud environment. We built the varvis® software with that responsibility in mind, and this attestation is independent proof that our controls work as designed. We are proud of the team that made it happen,” said Ben Liesfeld, Managing Director at Limbus.
The Cloud Computing Compliance Criteria Catalogue (C5), developed by Germany's Federal Office for Information Security (BSI), provides a framework for assessing the security of cloud services.
For clinical diagnostic laboratories, the secure handling of genomic data is an important consideration when selecting cloud-based software. As sequencing technologies and genomic analysis workflows continue to evolve, laboratories need solutions that support their diagnostic processes while addressing information security requirements.
The cloud-based varvis® software from Limbus Medical Technologies supports clinical diagnostic workflows across next-generation sequencing data processing, genomic data management, and variant interpretation.
This milestone complements Limbus’ existing certifications: its Quality Management System (QMS) is certified according to ISO 13485:2016, while the varvis® software (IVDR class C) holds a certificate under Regulation (EU) 2017/746 (IVDR). With quality and cloud security both independently assessed, the varvis® software offers laboratories and hospitals a single tool whose processes have been audited end to end, from software development to data hosting.
"Achieving C5 was a true team effort. Quality management and IT worked hand in hand from day one, and that close collaboration was the key to our success," said Inga Blunk, the regulatory expert responsible for the project at Limbus. Martin Garbe, Manager IT at Limbus, adds: "Achieving C5 meant reviewing every layer of our platform, from infrastructure and access management to incident response. The result is a cloud environment our customers can trust with sensitive clinical data."
About the varvis® software
The varvis® software is your complete solution for clinical diagnostics, combining NGS data processing, genomics data management, and variant interpretation in one seamless platform. Designed to streamline every step of the sequencing workflow, the varvis® software supports both short- and long-read technologies, enabling comprehensive genomic analysis from targeted panels to whole-genome sequencing. With automated analysis of SNVs, CNVs, STRs, and SVs, the varvis® software delivers robust performance, scalability, and accuracy across all panel sizes. It also serves as an integrated variant database for efficient knowledge management and full traceability. Now fully integrated with AION, the varvis® software brings AI-powered variant interpretation directly into your workflow. AION identifies and prioritizes disease-relevant variants, delivering a ranked shortlist and detailed report, and thus enabling faster, more confident diagnostics. As the first end-to-end genomics software certified as Class C under IVDR, the varvis® software sets the standard for clinical-grade performance and compliance.
Limbus Medical Technologies achieves C5 attestation for the varvis® software
Rostock, Germany, November 4, 2025 — Limbus Medical Technologies GmbH, a medical device manufacturer and software development company based in Rostock, Germany, has achieved C5 attestation (type 1). This milestone reinforces the company's commitment to information security in cloud-based clinical genomics. For laboratories and hospitals, the result is a certified, secure cloud service that supports their compliance requirements.
“C5 attestation confirms what our customers expect from us: that sensitive clinical data is handled in a secure, certified cloud environment. We built the varvis® software with that responsibility in mind, and this attestation is independent proof that our controls work as designed. We are proud of the team that made it happen,” said Ben Liesfeld, Managing Director at Limbus.
The Cloud Computing Compliance Criteria Catalogue (C5), developed by Germany's Federal Office for Information Security (BSI), provides a framework for assessing the security of cloud services.
For clinical diagnostic laboratories, the secure handling of genomic data is an important consideration when selecting cloud-based software. As sequencing technologies and genomic analysis workflows continue to evolve, laboratories need solutions that support their diagnostic processes while addressing information security requirements.
The cloud-based varvis® software from Limbus Medical Technologies supports clinical diagnostic workflows across next-generation sequencing data processing, genomic data management, and variant interpretation.
This milestone complements Limbus’ existing certifications: its Quality Management System (QMS) is certified according to ISO 13485:2016, while the varvis® software (IVDR class C) holds a certificate under Regulation (EU) 2017/746 (IVDR). With quality and cloud security both independently assessed, the varvis® software offers laboratories and hospitals a single tool whose processes have been audited end to end, from software development to data hosting.
"Achieving C5 was a true team effort. Quality management and IT worked hand in hand from day one, and that close collaboration was the key to our success," said Inga Blunk, the regulatory expert responsible for the project at Limbus. Martin Garbe, Manager IT at Limbus, adds: "Achieving C5 meant reviewing every layer of our platform, from infrastructure and access management to incident response. The result is a cloud environment our customers can trust with sensitive clinical data."
About the varvis® software
The varvis® software is your complete solution for clinical diagnostics, combining NGS data processing, genomics data management, and variant interpretation in one seamless platform. Designed to streamline every step of the sequencing workflow, the varvis® software supports both short- and long-read technologies, enabling comprehensive genomic analysis from targeted panels to whole-genome sequencing. With automated analysis of SNVs, CNVs, STRs, and SVs, the varvis® software delivers robust performance, scalability, and accuracy across all panel sizes. It also serves as an integrated variant database for efficient knowledge management and full traceability. Now fully integrated with AION, the varvis® software brings AI-powered variant interpretation directly into your workflow. AION identifies and prioritizes disease-relevant variants, delivering a ranked shortlist and detailed report, and thus enabling faster, more confident diagnostics. As the first end-to-end genomics software certified as Class C under IVDR, the varvis® software sets the standard for clinical-grade performance and compliance.